| Date Filed | Type | Description |
| 03/07/2023 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 4,403 shares
@ $76.1594, valued at
$335.3k
Sold 888 shares
@ $76.1594, valued at
$67.6k
Sold 6,003 shares
@ $74.9968, valued at
$450.2k
Sold 2,315 shares
@ $75.5937, valued at
$175k
|
|
| 03/06/2023 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 844 shares
@ $75.2779, valued at
$63.5k
Granted 11,808 shares
@ $0
Sold 2,059 shares
@ $77.6391, valued at
$159.9k
|
|
| 03/02/2023 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 18,621 shares
@ $0
Sold 1,684 shares
@ $76.3624, valued at
$128.6k
Granted 30,971 options to buy
@ $76.97, valued at
$2.4M
|
|
| 01/09/2023 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 2,345 shares
@ $119.0077, valued at
$279.1k
Sold 417 shares
@ $108, valued at
$45k
Sold 526 shares
@ $115.0348, valued at
$60.5k
Sold 1,010 shares
@ $117, valued at
$118.2k
Sold 7,826 shares
@ $108, valued at
$845.2k
Sold 7,500 shares
@ $108, valued at
$810k
Sold 5,517 shares
@ $108, valued at
$595.8k
Sold 7,183 shares
@ $114.0001, valued at
$818.9k
Sold 7,183 shares
@ $120, valued at
$862k
Exercised 7,826 options to buy
@ $14.37, valued at
$112.5k
Exercised 7,500 options to buy
@ $11.46, valued at
$86k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $76.01, valued at
$513.4k
|
|
| 10/07/2022 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $84.37, valued at
$569.8k
|
|
| 09/30/2022 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $77.35, valued at
$522.4k
|
|
| 09/26/2022 |
4
| Leonard Frank X (President, CNS Cancers US) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $77, valued at
$520.1k
|
|
| 09/19/2022 |
4
| Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $87.31, valued at
$589.7k
Sold 5,517 shares
@ $90, valued at
$496.5k
Exercised 5,517 options to buy
@ $7.15, valued at
$39.4k
|
|
| 09/13/2022 |
4/A
| Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 6,754 shares
@ $81.48, valued at
$550.3k
|
|
| 09/12/2022 |
4
| Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 1,863 shares
@ $88, valued at
$163.9k
|
|
| 09/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
3
| Leonard Frank X (Chief Development Officer) has filed a Form 3 on NovoCure Ltd |
| 09/04/2020 |
4
| Leonard Frank X (Chief Development Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 5,904 shares
@ $0
Granted 11,336 options to buy
@ $84.68, valued at
$959.9k
|
|